Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Ref Type | |||||||||||||
PMID | |||||||||||||
Authors | David Andrew Sallman, Monzr Al Malki, Adam Steven Asch, Daniel Junseung Lee, Suman Kambhampati, William Bruce Donnellan, Terrence James Bradley, Paresh Vyas, Deepa Jeyakumar, Guido Marcucci, Rami S. Komrokji, Joanna Van Elk, Ming Lin, Roy Maute, Jens-Peter Volkmer, Chris H.M. Takimoto, Mark Chao, Naval Guastad Daver | ||||||||||||
Title | Tolerability and efficacy of the first-in-class anti-CD47 antibody magrolimab combined with azacitidine in MDS and AML patients: Phase Ib results. | ||||||||||||
|
|||||||||||||
URL | https://meetinglibrary.asco.org/record/185295/abstract | ||||||||||||
Abstract Text | J Clin Oncol 38: 2020 (suppl; abstr 7507), DOI: 10.1200/JCO.2020.38.15_suppl.7507 |